Skip to main content
SpringerLink
Log in

New trends in the chemotherapy of tuberculosis — Current aspects

  • Review Article
  • Published:
Pneumonologie Aims and scope Submit manuscript

Abstract

A review of new achievements in tuberculosis chemotherapy in recent years is presented; new trends and concepts of treatment of tuberculosis are discussed. Emphasized are the new classification of the tuberculous agents, the role of the new drugs rifampicin and ethambutol in the new regimens particularly in chemotherapy programs. The current aspects of intermittent chemotherapy methods are discussed; their results in original treatment and re-treatment of tuberculosis are analyzed, based on our own studies and other publications. Today new principles in the applications of various treatment models, with new drug regimens, intermittent chemotherapy, and shortening of treatment duration in tuberculosis have been developed in a background of experimental and clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Madras, A.: A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis. Bull. WHO43, 143 (1970)

    PubMed  Google Scholar 

  2. Batten, J.: Rifampicin in the treatment of experimental tuberculosis in mice. Tubercle51, 95 (1970)

    PubMed  Google Scholar 

  3. Bignall, J. R., Lind, A., Rist, N.: A comparison of regimens ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis. Tuberc.42, 7–57 (1969)

    Google Scholar 

  4. Bignall, J. R., Rist, A.: A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. Bull. int. Un. Tuberc.44, 8–53 (1970)

    PubMed  Google Scholar 

  5. Cabral, J.: The importance of motivation in fully supervised ambulatory treatment. Bull. int. Un. Tuberc.47, 84 (1972)

    PubMed  Google Scholar 

  6. Cabral, J.: Controlled clinical trial of short-course (6 months) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet1972 I, 1079

    Google Scholar 

  7. Decroix, G.: Etude comparative du traitement de la tuberculose pulmonaire par l'association rifampicine-isoniazide administrée quotidiennement et deux fois par semaine pendant une anné. Rev. Tuberc. (Paris)35, 39–54 (1971)

    Google Scholar 

  8. Dubra, F.: Controlled therapeutic trial with the combination rifampicin isoniazid given for 6 months to previously untreated patients with pulmonary tuberculosis. Bull. int. Un. Tuberc.47, 37 (1972)

    PubMed  Google Scholar 

  9. Eule, H.: Gegenwärtiger Stand der Chemotherapie der Tuberkulose und ihre weitere Perspektive. Z. Ekr. Atmungsorg.134, 313 (1971)

    Google Scholar 

  10. Eule, H.: Preliminary results of a controlled therapeutic trial INH — RMP once weekly, after or without an initial period of continuous treatment. Scand. J. resp. (in press) 1973

  11. Farga, V.: Intermittent treatment of resistent pulmonary tuberculosis with ethambutol and rifampicin plus an initial 4 week supplement of kanamycin. Acta tuberc. pneumol. belg.62, 327 (1971)

    Google Scholar 

  12. Fox, W.: Changing concepts in the chemotherapy of pulmonary tuberculosis. Amer. Rev. resp. Dis.97, 676 (1968)

    Google Scholar 

  13. Fox, W.: General consideration in the choice and management of regimens of chemotherapy for pulmonary tuberculosis. Bull. int. Un. Tuberc.47, 49 (1972)

    Google Scholar 

  14. Fraga, H.: Intermittent rifampicin combined regimen after initial period of daily treatment in the re-treatment of pulmonary tuberculosis. Acta tuberc. pneumol. belg.62 (1971)

  15. Freerksen, E.: Fortschritte in der Tuberkulose-Behandlung. Isoniazid, Rifampicin, Myambutol „Standard-Therapie“. Dtsch. med. Wschr.95, 139 (1970)

    PubMed  Google Scholar 

  16. Gomi, J.: Symp. on Rifampicin. Stockholm, October 1972

  17. Grumbach, F., Canetti, G., Le Lirzin, M.: Rifampicin in daily and intermittent treatment of experimental murine tuberculosis with emphasis on late results. Tubercle50, 3 (1969)

    Google Scholar 

  18. Nitti, V., Catena, E., della Veneri, F.: Rifampicin in association with isoniazid, streptomycin and ethambutol in the initial treatment of pulmonary tuberculosis. Amer. Rev. resp. Dis.103, 329 (1971)

    PubMed  Google Scholar 

  19. Polańský, F.: Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy. Bull. int. Un. Tuberc.43 (1970)

  20. Radenbach, K. L.: Zum gegenwärtigen Stand der antituberkulösen Chemotherapie. Internist14, 100 (1973)

    PubMed  Google Scholar 

  21. Raleigh, J. W.: Rifampicin in treatment of advanced pulmonary tuberculosis. Amer. Rev. resp. Dis.105, 397 (1972)

    PubMed  Google Scholar 

  22. Riska, N., Mattson, K.: Adverse reactions during rifampicin treatment. Scand J. resp. Dis.53, 87–96 (1972)

    Google Scholar 

  23. Rist, N.: La resistance du bacille tuberculeus a la rifampicine. Rev. Tuberc. (Paris)33, suppl. 33, 38 (1969)

    Google Scholar 

  24. Verbist, L.: Experimentelle Grundlagen der intermittierenden Behandlung. Pneumonologie, Suppl.31 (1970)

  25. Verbist, L., Mbete, S., van Landwyt, Darras, Th., Gyselen, A.: Intermittent therapy with rifampicin once a week in advanced pulmonary tuberculosis. Chest61, 555 (1972)

    PubMed  Google Scholar 

  26. Zierski, M.: Intermittent rifampicin and ethambutol re-treatment of resistance chronic pulmonary tuberculosis. Symposium on Rifampicine, Prague, pp. 105–109 (1970)

  27. Zierski, M.: Neue Wege der Tuberkulosetherapie. Klinische Fragen zur Chemotherapie. Pneumonologie, Suppl. 70 (1970)

  28. Zierski, M.: Intermittent chemotherapy in pulmonary tuberculosis, current aspects. Pneumonologie146, 307–320 (1972)

    PubMed  Google Scholar 

  29. Zierski, M.: Meeting Scient. Committee on Treatment Int. Un. a. Tuber., Ankara, Sept. 7–8 (1970)

  30. Zierski, M., Bek, E., Zachara, A., Dąbrowska, Z.: Continuous and intermittent administration of standard drugs with supervised regimen in previously untreated pulmonary tuberculosis. Gruźlica i Choroby Płuc41, 2, 151 (1973)

    Google Scholar 

  31. Zierski, M.: A trial of intermittent rifampicin and ethambutol in re-treatment regimens. Scand. J. resp. Dis. Suppl.84, 1973

  32. Zierski, M.: Clinical aspects of side effects on intermittent rifampicin regimen. Scand. J. resp. Dis. Suppl.84, 1973

  33. Zierski, M., Bek, E.: Streptomycin, isoniazid and ethambutol in continuous and intermittent treatment of previously untreated pulmonary tuberculosis. Gruźlica i Choroby Płuc40, 12, 1165 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases and Tuberculosis, National Research Institute for Tuberculosis Łódź, Poland

    M. Zierski

Authors
  1. M. Zierski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zierski, M. New trends in the chemotherapy of tuberculosis — Current aspects. Pneumonologie 150, 1–12 (1973). https://doi.org/10.1007/BF02097148

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02097148

Key words

Search

Navigation